Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Find clear guidance on which blue chip coin to start with, including risk notes and a simple starter approach for newcomers.
22,235 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Analysts warn that the AI data center boom championed by leading tech firms may deliver far less capacity than promis...
SpaceX's debut sparked a major rise in the Saudi investor's wealth as Kingdom Holding's SpaceX stake climbed, signali...
Two heavyweight tech stocks have surged on AI bets, but investors face a stark choice: own NVIDIA stock or Micron sto...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
If you’re weighing big tech bets, Microsoft often outshines Apple on value. This guide breaks down why MSFT stands as...
Biogen’s $1 billion move on a mystery company has investors buzzing. This article breaks down why the deal could be a...
Colorado regulators announced a settlement with Unlock Technologies to reclassify home equity agreements as consumer ...
AI-driven models flag XRP as the most likely to post the biggest gains in the second half of 2026, even as Bitcoin an...
June retail sales rose modestly, led by auto purchases and a surge in online spending during Prime Day-like promotion...
Jamie Dimon drops a bold note on AI’s real impact at JPMorgan: it’s already trimming headcount in some units, but pro...